🇺🇸 FDA
Patent

US 11696896

Immunomodulatory nanoparticle treatment of brain injury

granted A61KA61K9/0019A61K9/5153

Quick answer

US patent 11696896 (Immunomodulatory nanoparticle treatment of brain injury) held by Northwestern University expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Jul 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K9/0019, A61K9/5153